OSE Immunotherapeutics SA banner

OSE Immunotherapeutics SA
PAR:OSE

Watchlist Manager
OSE Immunotherapeutics SA Logo
OSE Immunotherapeutics SA
PAR:OSE
Watchlist
Price: 4.746 EUR -3.38% Market Closed
Market Cap: €106.6m

Wall St Price Targets

OSE Price Targets Summary
OSE Immunotherapeutics SA

Wall Street analysts forecast OSE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for OSE is 10.812 EUR with a low forecast of 8.282 EUR and a high forecast of 13.65 EUR.

Lowest Forecast
Price Target
8.282 EUR
75% Upside
Average Forecast
Price Target
10.812 EUR
128% Upside
Highest Forecast
Price Target
13.65 EUR
188% Upside
OSE Immunotherapeutics SA Competitors:
Price Targets
MASI
Masimo Corp
1% Upside

Revenue
Forecast

N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
58% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

The compound annual growth rate for Revenue over the next 4 years is 58%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
36%
Average Beat

Net Income
Forecast

N/A
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
46% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate for Net Income over the next 4 years is 46%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OSE's stock price target?
Price Target
10.812 EUR

According to Wall Street analysts, the average 1-year price target for OSE is 10.812 EUR with a low forecast of 8.282 EUR and a high forecast of 13.65 EUR.

What is the Revenue forecast for OSE Immunotherapeutics SA?
Projected CAGR
58%

The compound annual growth rate for Revenue over the next 4 years is 58%.

What is the Net Income forecast for OSE Immunotherapeutics SA?
Projected CAGR
46%

The compound annual growth rate for Net Income over the next 4 years is 46%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett